Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets (Review)
- Authors:
- Nadège Kindt
- Fabrice Journe
- Guy Laurent
- Sven Saussez
-
Affiliations: Laboratory of Anatomy and Cellular Biology, Faculty of Medicine and Pharmacy, University of Mons, Mons 7000, Belgium, Laboratory of Histology, Faculty of Medicine and Pharmacy, University of Mons, Mons 7000, Belgium - Published online on: August 2, 2016 https://doi.org/10.3892/ol.2016.4929
- Pages: 2247-2253
This article is mentioned in:
Abstract
 |
|
Bloom and Bennett. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 153:80–82. 1966. View Article : Google Scholar : PubMed/NCBI | |
|
Sun HW, Bernhagen J, Bucala R and Lolis E: Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci USA. 93:5191–5196. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Leng L and Bucala R: Insight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptor. Cell Res. 16:162–168. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Rosengren E, Bucala R, Aman P, Jacobsson L, Odh G, Metz CN and Rorsman H: The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med. 2:143–149. 1996.PubMed/NCBI | |
|
Conroy H, Mawhinney L and Donnelly SC: Inflammation and cancer: Macrophage migration inhibitory factor (MIF)-the potential missing link. QJM. 103:831–836. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Nishino T, Bernhagen J, Shiiki H, Calandra T, Dohi K and Bucala R: Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med. 1:781–788. 1995.PubMed/NCBI | |
|
Roger T, Chanson AL, KnaupReymond M and Calandra T: Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur J Immunol. 35:3405–3413. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Santos LL and Morand EF: Macrophage migration inhibitory factor: A key cytokine in RA, SLE and atherosclerosis. Clin Chim Acta. 399:1–7. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Sánchez-Zamora YI and Rodriguez-Sosa M: The role of MIF in type 1 and type 2 diabetes mellitus. J Diabetes Res. 2014:8045192014.PubMed/NCBI | |
|
Rendon BE, Roger T, Teneng I, Zhao M, AlAbed Y, Calandra T and Mitchell RA: Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem. 282:29910–29918. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
He XX, Chen K, Yang J, Li XY, Gan HY, Liu CY, Coleman TR and Al-Abed Y: Macrophage migration inhibitory factor promotes colorectal cancer. Mol Med. 15:1–10. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Richard V, Kindt N, Decaestecker C, Gabius HJ, Laurent G, Noël JC and Saussez S: Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer. Oncol Rep. 32:523–529. 2014.PubMed/NCBI | |
|
Guo P, Wang J, Liu J, Xia M, Li W and He M: Macrophage immigration inhibitory factor promotes cell proliferation and inhibits apoptosis of cervical adenocarcinoma. Tumour Biol. 36:5095–5102. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
MeyerSiegler KL, Iczkowski KA, Leng L, Bucala R and Vera PL: Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol. 177:8730–8739. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kindt N, Preillon J, Kaltner H, Gabius HJ, Chevalier D, Rodriguez A, Johnson BD, Megalizzi V, Decaestecker C, Laurent G and Saussez S: Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: Clinical and experimental studies. J Cancer Res Clin Oncol. 139:727–737. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kindt N, Lechien JR, Nonclercq D, Laurent G and Saussez S: Involvement of CD74 in head and neck squamous cell carcinomas. J Cancer Res Clin Oncol. 140:937–947. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Dessein AF, Stechly L, Jonckheere N, Dumont P, Monté D, Leteurtre E, Truant S, Pruvot FR, Figeac M, Hebbar M, et al: Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells. Cancer Res. 70:4644–4654. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
He XX, Yang J, Ding YW, Liu W, Shen QY and Xia HH: Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: Potential role of MIF in gastric carcinogenesis. Gut. 55:797–802. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tan L, Ye X, Zhou Y, Yu M, Fu Z, Chen R, Zhuang B, Zeng B, Ye H, Gao W, et al: Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of β-cell. J Transl Med. 12:922014. View Article : Google Scholar : PubMed/NCBI | |
|
Heise R, VetterKauczok CS, Skazik C, Czaja K, Marquardt Y, Lue H, Merk HF, Bernhagen J and Baron JM: Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer. Photochem Photobiol. 88:1157–1164. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Huang XH, Jian WH, Wu ZF, Zhao J, Wang H, Li W and Xia JT: Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation. Oncotarget. 5:5570–5580. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Mittelbronn M, Platten M, Zeiner P, Dombrowski Y, Frank B, Zachskorn C, Harter PN, Weller M and Wischhusen J: Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression. Acta Neuropathol. 122:353–365. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao YM, Wang L, Dai Z, Wang DD, Hei ZY, Zhang N, Fu XT, Wang XL, Zhang SC, Qin LX, et al: Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma. Int J Cancer. 129:2463–2472. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
DeSouza MB, Curioni OA, Kanda JL and De Carvalho MB: Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma. Oncol Lett. 8:2267–2275. 2014.PubMed/NCBI | |
|
Cludts S, Decaestecker C, Johnson B, Lechien J, Leroy X, Kindt N, Kaltner H, André S, Gabius HJ and Saussez S: Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma. Anticancer Res. 30:3313–3319. 2010.PubMed/NCBI | |
|
Kindt N, Lechien J, Decaestecker C, Rodriguez A, Chantrain G, Remmelink M, Laurent G, Gabius HJ and Saussez S: Expression of macrophage migration-inhibitory factor is correlated with progression in oral cavity carcinomas. Anticancer Res. 32:4499–4505. 2012.PubMed/NCBI | |
|
Kamimura A, Kamachi M, Nishihira J, Ogura S, Isobe H, DosakaAkita H, Ogata A, Shindoh M, Ohbuchi T and Kawakami Y: Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung. Cancer. 89:334–341. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Tomiyasu M, Yoshino I, Suemitsu R, Okamoto T and Sugimachi K: Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance. Clin Cancer Res. 8:3755–3760. 2002.PubMed/NCBI | |
|
Wang D, Luo L, Chen W, Chen LZ, Zeng WT, Li W and Huang XH: Significance of the vascular endothelial growth factor and the macrophage migration inhibitory factor in the progression of hepatocellular carcinoma. Oncol Rep. 31:1199–1204. 2014.PubMed/NCBI | |
|
Chang KP, Lin SJ, Liu SC, Yi JS, Chien KY, Chi LM, Kao HK, Liang Y, Lin YT, Chang YS and Yu JS: Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma. Sci Rep. 5:116892015. View Article : Google Scholar : PubMed/NCBI | |
|
Oliveira CS, de Bock CE, Molloy TJ, Sadeqzadeh E, Geng XY, Hersey P, Zhang XD and Thorne RF: Macrophage migration inhibitory factor engages PI3K/AKT signalling and is a prognostic factor in metastatic melanoma. BMC Cancer. 14:6302014. View Article : Google Scholar : PubMed/NCBI | |
|
Funamizu N, Hu C, Lacy C, Schetter A, Zhang G, He P, Gaedcke J, Ghadimi MB, Ried T and Yfantis HG: Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma. Int J Cancer. 132:785–794. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Xia HH, Yang Y, Chu KM, Gu Q, Zhang YY, He H, Wong WM, Leung SY, Yuen ST, Yuen MF, et al: Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer. Cancer. 115:5441–5449. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
He LJ, Xie D, Hu PJ, Liao YJ, Deng HX, Kung HF and Zhu SL: Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer. World J Gastroenterol. 21:9916–9926. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E, et al: CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity. 25:595–606. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Mitchell RA, Liao H, Chesney J, FingerleRowson G, Baugh J, David J and Bucala R: Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response. Proc Natl Acad Sci USA. 99:345–350. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Li GQ, Xie J, Lei XY and Zhang L: Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/AKT pathway. World J Gastroenterol. 15:5541–5548. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Jung H, Seong HA and Ha H: Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J Biol Chem. 283:20383–20396. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Hagemann T, Robinson SC, Thompson RG, Charles K, Kulbe H and Balkwill FR: Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis. Mol Cancer Ther. 6:1993–2002. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Lu C, Xing G, Zhu Y and He F: Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell. Exp Cell Res. 300:379–387. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Hu CT, Guo LL, Feng N, Zhang L, Zhou N, Ma LL, Shen L, Tong GH, Yan QW, Zhu SJ, et al: MIF, secreted by human hepatic sinusoidal endothelial cells, promotes chemotaxis and outgrowth of colorectal cancer in liver prometastasis. Oncotarget. 6:22410–24423. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Baron N, Deuster O, Noelker C, Stüer C, Strik H, Schaller C, Dodel R, Meyer B and Bacher M: Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells. J Neurosci Res. 89:711–717. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kindt N, Laurent G, Nonclercq D, Journé F, Ghanem G, Duvillier H, Gabius HJ, Lechien J and Saussez S: Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells. Int J Oncol. 43:185–193. 2013.PubMed/NCBI | |
|
Ren Y, Chan HM, Fan J, Xie Y, Chen YX, Li W, Jiang GP, Liu Q, Meinhardt A and Tam PK: Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma. Oncogene. 25:3501–3508. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Pei XJ, Wu TT, Li B, Tian XY, Li Z and Yang QX: Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma. Int J Med Sci. 11:106–115. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Liu H, Chen G, Zhang W, Zhu JY, Lin ZQ, Gong ZC, Wang FQ, Jia J, Sun ZJ and Zhao YF: Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: Correlation with enhanced metastatic potential. J Cancer Res Clin Oncol. 139:287–295. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Oda S, Oda T, Nishi K, Takabuchi S, Wakamatsu T, Tanaka T, Adachi T, Fukuda K, Semenza GL and Hirota K: Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS One. 3:e22152008. View Article : Google Scholar : PubMed/NCBI | |
|
Xu X, Wang B, Ye C, Yao C, Lin Y, Huang X, Zhang Y and Wang S: Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett. 261:147–157. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Choudhary S, Hegde P, Pruitt JR, Sielecki TM, Choudhary D, Scarpato K, Degraff DJ, Pilbeam CC and Taylor JA III: Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis. Carcinogenesis. 34:2891–2899. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
White ES, Flaherty KR, Carskadon S, Brant A, Iannettoni MD, Yee J, Orringer MB and Arenberg DA: Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: Role in angiogenesis and prognosis. Clin Cancer Res. 9:853–860. 2003.PubMed/NCBI | |
|
Coleman AM, Rendon BE, Zhao M, Qian MW, Bucala R, Xin D and Mitchell RA: Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase. J Immunol. 181:2330–2337. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Hira E, Ono T, Dhar DK, ElAssal ON, Hishikawa Y, Yamanoi A and Nagasue N: Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma. Cancer. 103:588–598. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Girard E, Strathdee C, Trueblood E and Quéva C: Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model. Br J Cancer. 107:1498–1505. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Fu H, Luo F, Yang L, Wu W and Liu X: Hypoxia stimulates the expression of macrophage migration inhibitory factor in human vascular smooth muscle cells via HIF-1alpha dependent pathway. BMC Cell Biol. 11:662010. View Article : Google Scholar : PubMed/NCBI | |
|
Ioannou K, Cheng KF, Crichlow GV, Birmpilis AI, Lolis EJ, Tsitsilonis OE and Al-Abed Y: ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models. Int J Oncol. 45:1457–1468. 2014.PubMed/NCBI | |
|
Mawhinney L, Armstrong ME, O'Reilly C, Bucala R, Leng L, Fingerle-Rowson G, Fayne D, Keane MP, Tynan A, Maher L, et al: Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer. Mol Med. 20:729–735. 2015.PubMed/NCBI | |
|
Hussain F, Freissmuth M, Völkel D, Thiele M, Douillard P, Antoine G, Thurner P, Ehrlich H, Schwarz HP, Scheiflinger F and Kerschbaumer RJ: Human anti-macrophage migration inhibitory factor antibodies inhibit growth of human prostate cancer cells in vitro and in vivo. Mol Cancer Ther. 12:1223–1234. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Stein R, Mattes MJ, Cardillo TM, Hansen HJ, Chang CH, Burton J, Govindan S and Goldenberg DM: CD74: A new candidate target for the immunotherapy of B-cell neoplasms. Clin Cancer Res. 13:5556s–5563s. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Schulz R and Moll UM: Targeting the heat shock protein 90: A rational way to inhibit macrophage migration inhibitory factor function in cancer. Curr Opin Oncol. 26:108–113. 2014. View Article : Google Scholar : PubMed/NCBI |
